425 related articles for article (PubMed ID: 30340863)
1. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
[TBL] [Abstract][Full Text] [Related]
2. Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury.
Elder K; Hill DM; Hickerson WL
Burns; 2018 May; 44(3):658-664. PubMed ID: 29097070
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
5. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
Moffett BS; Morris J; Munoz F; Arikan AA
Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
Morrill HJ; Caffrey AR; Noh E; LaPlante KL
Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
[TBL] [Abstract][Full Text] [Related]
9. Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study.
Charoensareerat T; Chaijamorn W; Boonpeng A; Srisawat N; Pummangura C; Pattharachayakul S
J Crit Care; 2019 Dec; 54():77-82. PubMed ID: 31394493
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
[TBL] [Abstract][Full Text] [Related]
11. The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients.
Pan Y; He X; Yao X; Yang X; Wang F; Ding X; Wang W
BMC Infect Dis; 2020 May; 20(1):341. PubMed ID: 32404057
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance.
Molina KC; Hall ST; Barletta JF; Mangram AJ; Dzandu JK; Huang V
Surg Infect (Larchmt); 2020 Feb; 21(1):43-47. PubMed ID: 31335259
[No Abstract] [Full Text] [Related]
15. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
16. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
Brown DL; Lalla CD; Masselink AJ
Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.
Roberts JA; Taccone FS; Udy AA; Vincent JL; Jacobs F; Lipman J
Antimicrob Agents Chemother; 2011 Jun; 55(6):2704-9. PubMed ID: 21402850
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
